Show simple item record

dc.contributor.authorGray, Simon
dc.contributor.authorLamarca, Angela
dc.contributor.authorEdeline, J.
dc.contributor.authorKlumpen, H. J.
dc.contributor.authorHubner, Richard A
dc.contributor.authorMcNamara, Mairead G
dc.contributor.authorValle, Juan W
dc.date.accessioned2022-04-28T13:57:48Z
dc.date.available2022-04-28T13:57:48Z
dc.date.issued2022en
dc.identifier.citationGray S, Lamarca A, Edeline J, Klumpen HJ, Hubner RA, McNamara MG, et al. Targeted Therapies for Perihilar Cholangiocarcinoma. Cancers. 2022;14(7):19.en
dc.identifier.pmid35406560en
dc.identifier.doi10.3390/cancers14071789en
dc.identifier.urihttp://hdl.handle.net/10541/625181
dc.description.abstractPerihilar cholangiocarcinoma (pCCA) is the anatomical sub-group of biliary tract cancer (BTC) arising between the second-order intrahepatic bile ducts and the cystic duct. Together with distal and intrahepatic cholangiocarcinoma (dCCA and iCCA; originating distal to, and proximal to this, respectively), gallbladder cancer (GBC) and ampulla of Vater carcinoma (AVC), these clinicopathologically and molecularly distinct entities comprise biliary tract cancer (BTC). Most pCCAs are unresectable at diagnosis, and for those with resectable disease, surgery is extensive, and recurrence is common. Therefore, the majority of patients with pCCA will require systemic treatment for advanced disease. The prognosis with cytotoxic chemotherapy remains poor, driving interest in therapies targeted to the molecular nature of a given patient’s cancer. In recent years, the search for efficacious targeted therapies has been fuelled both by whole-genome and epigenomic studies, looking to uncover the molecular landscape of CCA, and by specifically testing for aberrations where established therapies exist in other indications. This review aims to provide a focus on the current molecular characterisation of pCCA, targeted therapies applicable to pCCA, and future directions in applying personalised medicine to this difficult-to-treat malignancy.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.3390/cancers14071789en
dc.titleTargeted Therapies for Perihilar Cholangiocarcinomaen
dc.typeArticleen
dc.identifier.journalCancersen
dc.description.noteen]
refterms.dateFOA2022-06-28T11:55:57Z


Files in this item

Thumbnail
Name:
GrayS.pdf
Size:
909.0Kb
Format:
PDF
Description:
Identified with Open Access button

This item appears in the following Collection(s)

Show simple item record